|
Aug 8
|
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
|
|
Aug 7
|
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 7
|
SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS
|
|
Jul 31
|
Cencora (COR) Surpasses Q3 Earnings and Revenue Estimates
|
|
Jul 25
|
Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024
|
|
Jul 9
|
Sera Prognostics PreTRM® Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial
|
|
May 28
|
SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES
|
|
May 10
|
Sera Prognostics Inc Reports Q1 2024 Results: A Closer Look at Financials and Strategic Moves
|
|
May 10
|
Sera Prognostics First Quarter 2024 Earnings: US$0.25 loss per share (vs US$0.34 loss in 1Q 2023)
|
|
May 9
|
Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript
|
|
May 8
|
SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS
|
|
Apr 29
|
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024
|
|
Dec 7
|
While institutions invested in Sera Prognostics, Inc. (NASDAQ:SERA) benefited from last week's 183% gain, retail investors stood to gain the most
|
|
Dec 6
|
SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS
|
|
Aug 9
|
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Tops Revenue Estimates
|
|
Aug 9
|
SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS
|
|
Apr 27
|
Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023
|